Kerr C R, Klein G J, Cooper J A, Sharma A D
Cardiovasc Clin. 1985;16(1):215-37.
Significant advances have been made in the therapy of ventricular arrhythmias. Many new antiarrhythmic drugs have expanded the medical armamentarium to treat ventricular tachycardia and ventricular fibrillation, and the use of intracardiac electrophysiologic studies has aided in predicting long-term drug efficacy. Major advances have also been made in the surgical treatment of arrhythmias. However, there remain a number of patients in whom ventricular arrhythmias remain a major therapeutic problem and, in some of these, electrical devices may aid in treatment. Overdrive pacing may prevent certain cases of ventricular arrhythmias, and antitachycardia devices may be useful in terminating paroxysmal ventricular tachycardia. In certain circumstances, internal cardioversion or defibrillation may be an alternative. At present, antitachycardia pacing and internal countershock must be considered as forms of therapy to be used when medical and surgical therapy are impractical or have failed. Careful selection is necessary to delineate patients in whom these forms of therapy may be indicated.
室性心律失常的治疗已取得显著进展。许多新型抗心律失常药物扩充了治疗室性心动过速和心室颤动的药物库,心内电生理研究的应用有助于预测药物的长期疗效。心律失常的外科治疗也取得了重大进展。然而,仍有许多患者的室性心律失常仍是主要的治疗难题,其中一些患者可能需要借助电子设备进行治疗。超速起搏可预防某些室性心律失常病例,抗心动过速设备可能有助于终止阵发性室性心动过速。在某些情况下,体内心脏复律或除颤可能是一种选择。目前,当药物治疗和手术治疗不实用或失败时,抗心动过速起搏和体内除颤必须被视为可供使用的治疗方式。必须仔细筛选以确定可能适用这些治疗方式的患者。